Who owns the HEPHAISTOS trademark?

The HEPHAISTOS trademark is owned by Celeris Therapeutics GmbH.

What class is the HEPHAISTOS trademark registered in?

The HEPHAISTOS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for HEPHAISTOS?

The USPTO serial number for HEPHAISTOS is 79322628.

What is the registration number for HEPHAISTOS?

HEPHAISTOS is registered under USPTO registration number 6874658.

Sealvo

Home Search: HEPHAISTOSHEPHAISTOS #79322628

Back

Updated Sep 18, 2026·9 searches this week

View on USPTO TSDR Find similar marks

HEP

USPTO Trademark Record

REGISTERED

HEPHAISTOS

SN 79322628·Reg 6874658·Filed Apr 29, 2021

Owner Celeris Therapeutics GmbH

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

HEPHAISTOS (Serial No. 79322628), Registration No. 6874658, is a registered US trademark filed on Apr 29, 2021 by Celeris Therapeutics GmbH. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: October 18, 2028

Conflict Analysis

Full conflict analysis for HEPHAISTOS (SN 79322628) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

HEPHAISTOS (Reg. #6874658) is a registered US trademark that has been protecting its owner, Celeris Therapeutics GmbH, since 2021. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 3 opposition proceedings during prosecution.

FILED

Apr 29, 2021

SERIAL

79322628

REG#

6874658

REGISTERED

Oct 18, 2022

Filing Information

StatusREGISTERED

Filing DateApr 29, 2021

Serial Number79322628

Registration No.6874658

Registration DateOct 18, 2022

Status DateOct 18, 2022

Published for OppositionAug 02, 2022

Filing Basis & Declarations

Standard Characters Claimed

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

32 events

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 01, 2025

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 01, 2025

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 01, 2025

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Oct 22, 2024

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Oct 22, 2024

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Oct 22, 2024

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Oct 22, 2024

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

FINAL DECISION TRANSACTION PROCESSED BY IB

Mar 06, 2023

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION NOTICE SENT TO IB

Feb 11, 2023

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION PROCESSED

Feb 10, 2023

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jan 18, 2023

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Oct 18, 2022

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Oct 18, 2022

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Aug 02, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 02, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Aug 02, 2022

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 13, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Jul 13, 2022

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Jul 13, 2022

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 27, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 24, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 24, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 24, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Feb 20, 2022

REFUSAL PROCESSED BY IB

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Feb 03, 2022

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

REFUSAL PROCESSED BY MPU

Feb 02, 2022

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jan 12, 2022

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Jan 11, 2022

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Dec 29, 2021

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Oct 23, 2021

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 19, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Oct 14, 2021

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by Celeris Therapeutics GmbH

Additional USPTO filings from the same owner.

HAD

HADES

79322626

Celeris Therapeutics GmbH

REGISTERED

XAN

XANTHOS

79322627

Celeris Therapeutics GmbH

REGISTERED

CEL

CELERIS THERAPEUTICS

79377993

Celeris Therapeutics GmbH

ABANDONED

CEL

CELERISTX

79377994

Celeris Therapeutics GmbH

ABANDONED

Other Marks by Vincent J. Badolato

Additional USPTO filings handled by the same attorney of record.

DGX

DGX SPARK

99599799

REGISTERED

AKT

AKTIS

90622804

REGISTERED

AKT

AKTIS ONCOLOGY

90561087

REGISTERED

A4T

A4TE

99158815

REGISTERED

HEPHAISTOS

Run a conflict check

Other Marks by Celeris Therapeutics GmbH

Other Marks by Vincent J. Badolato

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company